Sildenafil
Product Images NDC 60687-416

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 60687-416). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

33342 0121 10 Nlmimage10 2547928c

FDA Label Image

Image 01

Image 01
This is a description of Sildenafil Tablets, USP. The tablets come in a package that contains 30 tablets, i.e., 3 boxes of 10 tablets each. The usual dosage information is mentioned in the package insert. The tablets should be stored between 20-25°C, and excursions are permitted between 15-30°C. The packaging has a NDC code of 60687-416-21, and the drug product is from NOC # 68001363, BuePoint Laboratories. The tablets are Rx only, and the pharmacist is advised to dispense them with accompanying patient information leaflets. The usual dosage and administration information can be found in the package insert. The tablets should be kept out of reach of children and should not be used if the blister pack is torn or broken.*
FDA Label Image

Image 02

FDA Label Image

Figure-10 (Sildenafil Fig 10)

FDA Label Image

Figure-11 (Sildenafil Fig 11)

FDA Label Image

Figure 12 (Sildenafil Fig 12)

Figure 12 (Sildenafil Fig 12)
This document appears to be a graph representing the mean change from baseline in meters for different treatments at various points in a study that lasted up to 12 weeks. The treatments appear to be different dosages of a drug called Sildenafil.*
FDA Label Image

Fig-6 (Sildenafil Fig 6)

FDA Label Image

Fig-8 (Sildenafil Fig 8)

Fig-8 (Sildenafil Fig 8)
This is a table of recommendations for fold change and 90% confidence interval for different drugs and their interactions. The table also includes whether or not a dose adjustment is required for each drug. There are a variety of medications listed, such as aspirin, atorvastatin, and saquinavir, and their interactions with other drugs. The table also includes a graph showing the relative change of interacting drugs when compared to the drug alone, with vertical lines indicating the level of change.*
FDA Label Image

Figure 9 (Sildenafil Fig 9)

FDA Label Image

Figure-7 (Sildenafil Figure 7)

Figure-7 (Sildenafil Figure 7)
This is a chart that provides recommendations on drug dosage adjustments based on the percentage change and %0% CI in various drugs such as Atorasttn, Astromycn UG, Bosentan, Cimetidine, Evermyel:f, beoanod c, Oral Contraceptives, and Saquinavie. However, there is also a note indicating that there is no benefit concerning exercise capacity when sildenafil is added to bosentan therapy.*
FDA Label Image

Str (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.